The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline
Recommended Citation
Ragel BT, Ryken TC, Kalkanis SN, Ziu M, Cahill D, and Olson JJ. The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. J Neurooncol 2015; 125(3):481-501.
Document Type
Article
Publication Date
12-1-2015
Publication Title
Journal of neuro-oncology
Abstract
QUESTION: What is the optimal role of biopsy in the initial management of presumptive low-grade glioma in adults?
TARGET POPULATION: Adult patients with imaging suggestive of a low-grade glioma.
LEVEL III: Stereotactic biopsy is recommended when definitive surgical resection is limited by lesions that are deep-seated, not resectable, and/or located within eloquent cortex, or in patients unable to undergo craniotomy due to medical co-morbidities to obtain the critical tissue diagnosis needed for targeted treatment planning for patients with low-grade gliomas.
QUESTION: What is the best technique for brain biopsy?
TARGET POPULATION: Adult patients with imaging suggestive of a low-grade glioma.
LEVEL III: Frameless and frame-based stereotactic brain biopsy for low-grade gliomas are recommended based on clinical circumstances as they provide similar diagnostic yield, diagnostic accuracy, morbidity, and mortality. It is recommended the surgeon consider advanced imaging techniques (e.g., perfusion, spectroscopy, metabolic studies) to target specific regions of interest to potentially improve diagnostic accuracy.
Medical Subject Headings
Biopsy; Brain; Brain Neoplasms; Disease Management; Evidence-Based Medicine; Glioma; Humans; Neoplasm Grading; Neurosurgical Procedures
PubMed ID
26530259
Volume
125
Issue
3
First Page
481
Last Page
501